Catalyst Wire Dossier Catalyst Wire Dossier

Norketotifen

norketotifen · Emergo Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Norketotifen, covering 2020-08-21 to 2023-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness [Phase 2]

See pricing